Cargando…

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma

With the progress of precision medicine treatment in pancreatic ductal adenocarcinoma (PDAC), individualized cancer-related examination and prediction is of great importance in this high malignant tumor, and antibody-dependent cell phagocytosis (ADCP) with changed pathways highly enrolled in the car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Deyu, Cui, Fang, Peng, Lisi, Wang, Meiqi, Yang, Xiaoli, Xia, Chuanchao, Li, Keliang, Yin, Hua, Zhang, Yang, Yu, Qihong, Jin, Zhendong, Huang, Haojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417234/ https://www.ncbi.nlm.nih.gov/pubmed/35963640 http://dx.doi.org/10.18632/aging.204221

Ejemplares similares

Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients
por: Zhang, Deyu, et al.
Publicado: (2021)

The value of artificial intelligence techniques in predicting pancreatic ductal adenocarcinoma with EUS images: A meta-analysis and systematic review
por: Yin, Hua, et al.
Publicado: (2022)

Novel insight on marker genes and pathogenic peripheral neutrophil subtypes in acute pancreatitis
por: Zhang, Deyu, et al.
Publicado: (2022)

Methods of a New Chronic Pancreatitis and Spontaneous Pancreatic Cancer Mouse Model Using Retrograde Pancreatic Duct Injection of Dibutyltin Dichloride
por: Zhang, Deyu, et al.
Publicado: (2022)

Single-cell sequencing reveals heterogeneity between pancreatic adenosquamous carcinoma and pancreatic ductal adenocarcinoma with prognostic value
por: Zhang, Deyu, et al.
Publicado: (2022)

The Global Status and Trends of Enteropeptidase: A Bibliometric Study
por: Yang, Xiaoli, et al.
Publicado: (2022)

Bibliometric Analysis of Cathepsin B Research From 2011 to 2021
por: Yang, Xiaoli, et al.
Publicado: (2022)

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes
por: Huang, Xin, et al.
Publicado: (2023)

A Sample-Sparing Multiplexed ADCP Assay
por: Butler, Audrey L., et al.
Publicado: (2019)

Dynamic Optimization Method for Broadband ADCP Waveform with Environment Constraints
por: Yang, Yongshou, et al.
Publicado: (2021)

Cryo-EM structures reveal the activation and substrate recognition mechanism of human enteropeptidase
por: Yang, Xiaoli, et al.
Publicado: (2022)

Trends of calcium silicate biomaterials in medical research and applications: A bibliometric analysis from 1990 to 2020
por: Yin, Hua, et al.
Publicado: (2022)

Measuring a Lagrangian drifter’s slip with an onboard ADCP
por: Herrera, J.L., et al.
Publicado: (2019)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
por: Song, Wenjing, et al.
Publicado: (2021)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Xu, Yongfeng, et al.
Publicado: (2022)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

A COMPREHENSIVE ALZHEIMER’S AND DEMENTIA CARE PROGRAM (ADCP) FOR PATIENTS AND CAREGIVERS
por: Ramirez, Madieska, et al.
Publicado: (2022)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2020)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
por: Vezakis, Ioannis, et al.
Publicado: (2023)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
por: Schnipper, Julie, et al.
Publicado: (2020)

Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
por: Kruger, Deirdré, et al.
Publicado: (2022)

Factors and techniques associated with endoscopic retrograde cholangiopancreatography outcomes in patients with periampullary diverticulum: Results from a large tertiary center
por: Xia, Chuanchao, et al.
Publicado: (2022)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma
por: Chen, Kai, et al.
Publicado: (2022)

Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_no909hkopu4mmffns0uh3dpdop